These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25726053)

  • 1. Premalignant cystic neoplasms of the pancreas.
    Dudeja V; Allen PJ
    Semin Oncol; 2015 Feb; 42(1):70-85. PubMed ID: 25726053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biomarkers have the potential to improve the diagnostic work-up of pancreatic cystic lesions.
    Plougmann JI; Klausen P; Karstensen JG; Vilmann P; Hasselby JP; Hansen CP; Kalaitzakis E
    Scand J Gastroenterol; 2017 Sep; 52(9):932-940. PubMed ID: 28552018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum and Classification of Cystic Neoplasms of the Pancreas.
    Greer JB; Ferrone CR
    Surg Oncol Clin N Am; 2016 Apr; 25(2):339-50. PubMed ID: 27013368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
    Henry JC; Bassi C; Giovinazzo F; Bloomston M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic lesions of the pancreas: more reliable differentiation with in situ high-resolution optical imaging?
    Iftimia N; Yoon WJ; Brugge WR
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):125-7. PubMed ID: 22375515
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas.
    Jeurnink SM; Vleggaar FP; Siersema PD
    Dig Liver Dis; 2008 Nov; 40(11):837-46. PubMed ID: 18499541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
    Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
    Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification, morphology and molecular pathology of premalignant lesions of the pancreas.
    Cooper CL; O'Toole SA; Kench JG
    Pathology; 2013 Apr; 45(3):286-304. PubMed ID: 23442735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary mucinous neoplasms and other pancreatic cystic lesions.
    Freeman HJ
    World J Gastroenterol; 2008 May; 14(19):2977-9. PubMed ID: 18494045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification and malignant potential of pancreatic cystic tumors].
    Esposito I; Schlitter AM; Sipos B; Klöppel G
    Pathologe; 2015 Feb; 36(1):99-112; quiz 113-4. PubMed ID: 25663186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cystic and solid pancreatic incidentalomas: a review analysis.
    Karatzas T; Dimitroulis D; Charalampoudis P; Misiakos EP; Vasileiadis I; Kouraklis G
    J BUON; 2013; 18(1):17-24. PubMed ID: 23613384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of suspected pancreatic cystic neoplasms based on cyst size.
    Walsh RM; Vogt DP; Henderson JM; Hirose K; Mason T; Bencsath K; Hammel J; Brown N
    Surgery; 2008 Oct; 144(4):677-84; discussion 684-5. PubMed ID: 18847654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PANDA cyst-fluid analysis: eats, shoots and leaves?
    Anderson MA; Kwon RS; Scheiman JM
    Gastrointest Endosc; 2009 May; 69(6):1103-5. PubMed ID: 19410042
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
    El Gammal AT; Izbicki JR
    Surg Clin North Am; 2018 Feb; 98(1):141-155. PubMed ID: 29191271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is surgical intervention for cystic neoplasms of the pancreas being underutilized?
    Schmidt CM
    J Gastrointest Surg; 2014 Jan; 18(1):184-6. PubMed ID: 24170607
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic endometrial cyst mimics mucinous cystic neoplasm of the pancreas.
    Mederos MA; Villafañe N; Dhingra S; Farinas C; McElhany A; Fisher WE; Van Buren Ii G
    World J Gastroenterol; 2017 Feb; 23(6):1113-1118. PubMed ID: 28246486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cystic tumours: when to resect, when to observe.
    Salvia R; Crippa S; Partelli S; Malleo G; Marcheggiani G; Bacchion M; Butturini G; Bassi C
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):395-406. PubMed ID: 20496554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.